Actively Recruiting
The Effectiveness of Preoperative Iron Therapy in Improving Anemia After Multi-level Lumbar Fusion in the Elderly
Led by Xuanwu Hospital, Beijing · Updated on 2025-07-10
100
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Preoperative iron therapy has important value in improving the outcomes after lumbar fusion surgery, but there is significant heterogeneity in both domestic and international studies. International studies provide high-level evidence-based evidence for intravenous iron, but lack spinal surgery-specific data; domestic studies focus on the comparison of iron types and the improvement of clinical practice, but high-quality evidence is still insufficient. At present, there are still few studies on preoperative iron therapy in the field of spinal surgery, especially its specific impact on the prognosis of patients after lumbar fusion surgery is still unclear. Therefore, it is particularly important to study the preoperative iron supplementation regimen for lumbar fusion surgery to improve the efficacy and safety. Through multidisciplinary collaboration and technological innovation, preoperative iron therapy is expected to become an important part of accelerated recovery after lumbar fusion surgery.
CONDITIONS
Official Title
The Effectiveness of Preoperative Iron Therapy in Improving Anemia After Multi-level Lumbar Fusion in the Elderly
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing multi-segment lumbar spine surgery
- Iron deficiency anemia patients aged 65 years or older (men: hemoglobin less than 120 g/dL; women: hemoglobin less than 110 g/dL)
- Completion of relevant questionnaire surveys
You will not qualify if you...
- Age less than 65 years
- Previous spinal surgery for tumors, trauma, or infection
- Presence of inflammatory or immune diseases, acute kidney injury, progressive cancer, or porphyria cutanea tarda
- Surgery on non-adjacent spinal segments
- History of allergy to ferric carboxymaltose or intravenous iron, asthma, atopic dermatitis, or other allergies
- Decompensated liver cirrhosis or microcytic anemia
- Incomplete clinical data
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Xuanwu Hospital, Capital Medical University
Beijing, Beijing Municipality, China, 10053
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here